DARA BioSciences, Inc. (DARA)

[LaJollaCA]

Here's an article from Jason.


We should hear back on ODS in the next several weeks. If DARA gets ODS on KRN5500, congratulation to them. If not, do not cry over it. There are new formulation patent applications filed that aim to protect the drug until 2029. Approval as a new chemical entity (NCE) will protect KRN5500 for a minimum of five years, regardless of ODS. Plus, Management tells us that they are in partnership discussions for the drug, regardless. Is management leading investors on? I do not know. That is a risk inherent to investing in all stocks.

http://bionapcfa.blogspot.com/